{"id":"CHEMBL1018","canonicalSmiles":"C/C=C(C(=C/C)/c1ccc(O)cc1)\\c1ccc(O)cc1","inchiKey":"NFDFQCUYFHCNBW-SCGPFSFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIENESTROL","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dienestrol","Estraguard","Hormofemin"],"synonyms":["Dienestrol"],"crossReferences":{"PubChem":["124883370","144203929","170465362","26746961","56422141","855694"],"Wikipedia":["Dienestrol"],"drugbank":["DB00890"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1947."}
{"id":"CHEMBL1021","canonicalSmiles":"NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N","inchiKey":"QEFAQIPZVLVERP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPAFENAC","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilevro","Nepafenac","Nevanac"],"synonyms":["AHR-9434","AL-6515","Nepafenac"],"crossReferences":{"DailyMed":["nepafenac"],"PubChem":["124896627","144206538","170465203"],"Wikipedia":["Nepafenac"],"drugbank":["DB06802"],"chEBI":["75922"]},"count":5,"approvedIndications":["MP_0001845","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0003005","EFO_0001059","MP_0001845","EFO_1001231","HP_0000545","HP_0100014","EFO_0003770","HP_0000540","EFO_0009321","EFO_0003843","EFO_0005752","HP_0000616"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for eye inflammation and inflammation and has 3 investigational indications."}
{"id":"CHEMBL1076637","canonicalSmiles":"N[C@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"OUYCCCASQSFEME-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-Tyrosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Tyrosine"],"crossReferences":{"PubChem":["26754407","26754408"],"drugbank":["DB03839"],"chEBI":["28479"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1080983","canonicalSmiles":"COCC(=O)Nc1cc(Sc2ccccc2)ccc1N/C(=N\\C(=O)OC)NC(=O)OC","inchiKey":"HMCCXLBXIJMERM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEBANTEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Combotel","Negabot plus paste","Oratel","Rintal"],"synonyms":["BAY H 5757","BAY VH 5757","Febantel"],"crossReferences":{"PubChem":["144206335","50125904"],"drugbank":["DB11409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108821","canonicalSmiles":"N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2","inchiKey":"PNUZDKCDAWUEGK-CYZMBNFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAFLOXACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sitafloxacin hydrate","Sitafloxacin sesquihydrate"],"crossReferences":{"Wikipedia":["Sitafloxacin"],"chEBI":["4304"]},"childChemblIds":["CHEMBL3989504"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL11122","canonicalSmiles":"COc1nc(C(Cl)(Cl)Cl)c(Cl)c(O)c1Cl","inchiKey":"GUYGGZGIKZIRFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["519402"],"drugbank":["DB06331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1169490","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)S2)c(=O)n1","inchiKey":"MOMUJZRKXYLWMH-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4'-THIO-2'-DEOXYCYTIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4'-thio-2'-deoxycytidine","NSC-764276","Tdcyd"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1187646","canonicalSmiles":"NCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"BABFYCSPNDKXRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERPHENAZINE 4-AMINOBUTYRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perphenazine 4-aminobutyrate"],"childChemblIds":["CHEMBL513521"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1200406","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O","inchiKey":"NFLLKCVHYJRNRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMENHYDRINATE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antemin","Dimenhydrinate","Dramamine","Vertigo-vomex s"],"synonyms":["Chloranautine","Dimenhydrinate","NSC-117855"],"crossReferences":{"DailyMed":["dimenhydrinate"],"DrugCentral":["901"],"PubChem":["11112942","144207521","17389041","26747407"],"Wikipedia":["Dimenhydrinate"],"drugbank":["DB00985"]},"count":3,"approvedIndications":["HP_0002013"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_1001463","HP_0002321","EFO_0004888","HP_0002013","MONDO_0004900","HP_0002018"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for vomiting and has 2 investigational indications."}
{"id":"CHEMBL1200429","canonicalSmiles":"O.OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"LXMBXZRLTPSWCR-XBLONOLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1200429","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1661","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212600","49648466"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200516","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.Cl","inchiKey":"UPRWQSQENCASAD-HBBGHHHDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GONADORELIN HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1007","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Factrel"],"synonyms":["AY-24,031","AY-24031","Gonadorelin hydrochloride","Luteinizing hormone-releasing factor dihydrochloride"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200570","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"MBBZMMPHUWSWHV-BDVNFPICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Meglumine","N-methylglucamine","NSC-52907","NSC-7391"],"crossReferences":{"PubChem":["144205883","144212354","170465359"],"chEBI":["59732"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200804","canonicalSmiles":"O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]","inchiKey":"KXZOIWWTXOCYKR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC POTASSIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cambia","Cataflam","Diclofenac potassium","Voltarol joint pain","Voltarol pain-eze","Voltarol pain-eze extra strgh","Voltarol rapid","Zipsor"],"synonyms":["CGP 45840B","CGP-45840B","Diclofenac potassium","Diclofenac potassium salt"],"crossReferences":{"DailyMed":["diclofenac%20potassium"],"chEBI":["4508"]},"count":8,"approvedIndications":["EFO_0000685","EFO_0002506","EFO_0003821","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0009454","EFO_0000685","EFO_1001139","EFO_0002506","HP_0002373","EFO_0000544","EFO_0009582","EFO_0003821","HP_0001945","EFO_0010072","HP_0100607","EFO_0003843"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200939","canonicalSmiles":"Cl.N","inchiKey":"NLXLAEXVIDQMFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ammonium chloride","Chlorammonic","Tussi ammon co"],"synonyms":["Ammonium chloride","E510","FEMA NO. 4494"],"crossReferences":{"DrugCentral":["4350"],"drugbank":["DB06767"],"chEBI":["31206"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200940","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O","inchiKey":"KJBLQGHJOCAOJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOCLOPRAMIDE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL86","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["\"clopra-\"\"yellow\"\"\"","Clopra","Clopra-\"Yellow\"","Gastrese l.a.","Gastrobid continus","Gastroflux","Gastromax","Gimoti","Maxolon","Maxolon sr","Metoclomex","Metoclopramide hydrochloride","Metoclopramide intensol","Metox","Metozolv odt","Metramid","Mygdalon","Parmid","Primperan","Reglan","Reglan odt"],"synonyms":["AHR-3070-C","Metipamid","Metoclopramide dihydrochloride monohydrate","Metoclopramide hydrochloride","Metoclopramide hydrochloride monohydrate","Metoclopramide monohydrochloride monohydrate"],"crossReferences":{"DailyMed":["metoclopramide%20hydrochloride"],"chEBI":["6899"]},"count":3,"approvedIndications":["HP_0002017","EFO_0004888"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["EFO_1001463","HP_0002017","EFO_0004888","HP_0002013","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for nausea and vomiting and post operative nausea and vomiting and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201117","canonicalSmiles":"COc1ccccc1OCC(O)COC(N)=O","inchiKey":"GNXFOGHNGIVQEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOCARBAMOL","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delaxin","Forbaxin","Methocarbamol","Miolaxin","Neuraxin","Robaxin","Robaxin-750"],"synonyms":["Methocarbamol","NSC-170960"],"crossReferences":{"DailyMed":["methocarbamol"],"PubChem":["144204005","170464808","174006834","26747217","26747218","56422407","855587"],"Wikipedia":["Methocarbamol"],"drugbank":["DB00423"],"chEBI":["77498"]},"count":2,"linkedTargets":{"rows":["ENSG00000133742"],"count":1},"linkedDiseases":{"rows":["EFO_0001422","EFO_0003931","HP_0003419","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 2 investigational indications."}
{"id":"CHEMBL1201387","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21","inchiKey":"AHYHTSYNOHNUSH-HXFGRODQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANDOLAPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trandolaprilat"],"crossReferences":{"drugbank":["DB14209"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201438","drugType":"Protein","blackBoxWarning":true,"name":"ALDESLEUKIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proleukin"],"synonyms":["Aldesleukin","Human interleukin-2","Interleukin 2","Interleukin-2 aldesleukin"],"crossReferences":{"DailyMed":["aldesleukin"],"DrugCentral":["5011"]},"count":97,"approvedIndications":["EFO_0000756","EFO_0000389","EFO_0002617"],"linkedTargets":{"rows":["ENSG00000134460","ENSG00000100385"],"count":2},"linkedDiseases":{"rows":["EFO_1000403","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1000984","EFO_1001951","MONDO_0000548","EFO_0000339","EFO_0000588","EFO_0002690","EFO_0000096","MONDO_0008903","EFO_1000251","EFO_0001668","MONDO_0024885","EFO_0000198","EFO_0000221","MONDO_0013730","EFO_0000180","EFO_1001806","EFO_0000384","MONDO_0008315","MONDO_0002691","MONDO_0000544","EFO_0000574","EFO_0001378","EFO_0001376","EFO_0005672","EFO_0001062","EFO_1001465","MONDO_0007254","MONDO_0002158","MONDO_0002050","EFO_0000183","EFO_0000616","EFO_1001779","EFO_0000765","EFO_0006859","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_0000222","MONDO_0007576","EFO_0004599","EFO_1000954","EFO_1001471","EFO_0000764","MONDO_0002367","MONDO_0018906","MONDO_0024880","MONDO_0024475","EFO_0000729","EFO_0003869","EFO_0001075","EFO_0003780","MONDO_0000956","EFO_1000131","EFO_1001148","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0009709","HP_0001871","EFO_0000389","EFO_0000182","EFO_0000330","EFO_0004255","EFO_0000783","EFO_0000253","EFO_1000785","EFO_0003802","EFO_0003893","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0000223","MONDO_0044881","EFO_0003025","EFO_0004239","EFO_0009708","MONDO_0019956","EFO_0004192","EFO_0001359","EFO_0002428","EFO_1001051","EFO_0000218","EFO_0003812","MONDO_0015686","EFO_1001945","EFO_1001264","MONDO_0002087","MONDO_0001187","EFO_0008518","EFO_1001480","EFO_1000044","EFO_1000218","Orphanet_906","EFO_0005846","EFO_0000673","EFO_0003047","EFO_0002617","EFO_1000158","EFO_1000616","EFO_0000621","EFO_0003029","EFO_0003060","EFO_0000311","EFO_0003865","EFO_0006861","EFO_0000095","EFO_0001421","MONDO_0020077","EFO_0000691","EFO_0003027","EFO_0003811"],"count":116},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved and 94 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201520","drugType":"Unknown","blackBoxWarning":false,"name":"UROFOLLITROPIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bravelle","Fertinex","Fostimon","Gonadotraphon fsh","Metrodin","Metrodin high purity","Orgafol","Urofollitrophin"],"synonyms":["Urofollitropin"],"crossReferences":{"Wikipedia":["Urofollitropin"]},"count":4,"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0000545","EFO_0000279","MONDO_0002775"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications."}
{"id":"CHEMBL1201622","drugType":"Unknown","blackBoxWarning":false,"name":"PORACTANT ALFA","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Curosurf"],"synonyms":["CHF-6440 COMPONENT PORACTANT ALFA","Poractant Alfa","Poractant alfa"],"crossReferences":{"DailyMed":["poractant%20alfa"],"DrugCentral":["5148"]},"count":2,"approvedIndications":["EFO_1000644"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for newborn respiratory distress syndrome and has 1 investigational indication."}
{"id":"CHEMBL1204628","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XOFLBQFBSOEHOG-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1204628","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01864"],"chEBI":["43000"]},"childChemblIds":["CHEMBL1627119"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231708","canonicalSmiles":"C[C@](O)(CO)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O","inchiKey":"YFAUKWZNPVBCFF-XHIBXCGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03687"],"chEBI":["16578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234276","canonicalSmiles":"O=S(=O)(O)CCN1CCOCC1","inchiKey":"SXGZJKUKBWWHRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234276","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4242518"],"drugbank":["DB03814"],"chEBI":["39408"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236620","canonicalSmiles":"CCOC(=O)c1c(/C(C#N)=C\\N)c2ccc(Cl)c(Cl)c2n1C","inchiKey":"CXJCGSPAPOTTSF-VURMDHGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256686","canonicalSmiles":"CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O","inchiKey":"HIYAVKIYRIFSCZ-CYEMHPAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-23187","ANTIBIOTIC A-23187","Calcimycin"],"crossReferences":{"PubChem":["26732633","50104781","90341142"],"Wikipedia":["A23187"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL12760","canonicalSmiles":"Cn1cc(C(=O)Cc2ccccc2)cc1/C=C/C(=O)NO","inchiKey":"UFQOXIMRSMFQRI-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL12760","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1314751","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"DSKIOWHQLUWFLG-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCHLORPERAZINE MALEATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL728","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buccastem","Buccastem m","Compazine","Prochlorperazine maleate","Procomp","Proziere","Vertigon"],"synonyms":["Prochlorperazine maleate"],"crossReferences":{"DailyMed":["prochlorperazine%20maleate"],"PubChem":["144207071","170464761","50106935"],"chEBI":["8436"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1377408","canonicalSmiles":"Cl.O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1","inchiKey":"MVOWQBJZZKOQNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIPEXIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL254857","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204947","144212786","170466461","26748744","56463374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1412041","canonicalSmiles":"C[C@H](N)[C@@H](O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-IONNQARKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CATHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cathine"],"crossReferences":{"PubChem":["11112311"],"drugbank":["DB01486"],"chEBI":["4109"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1444","canonicalSmiles":"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1","inchiKey":"HPJKCIUCZWXJDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETROZOLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femara","Letrozole"],"synonyms":["CGS 20267","CGS-20267","Letrozole"],"crossReferences":{"DailyMed":["letrozole"],"PubChem":["11112889","124882709","144204270","144213877"],"Wikipedia":["Letrozole"],"drugbank":["DB01006"],"chEBI":["6413"]},"count":38,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0003869","Orphanet_64739","EFO_1001346","EFO_0001075","EFO_0003859","EFO_0001065","MONDO_0015686","MONDO_0003061","MONDO_0007254","Orphanet_538","MONDO_0002087","EFO_0005952","EFO_0003882","EFO_0000305","EFO_1000984","MONDO_0018555","EFO_0002950","MONDO_0002158","EFO_0000588","EFO_0000564","EFO_0000279","EFO_1000251","MONDO_0002715","EFO_0001416","EFO_0000616","EFO_0008509","Orphanet_145","EFO_0000186","EFO_0000545","MONDO_0004658","EFO_1001757","MONDO_0008170","EFO_1001512","EFO_0000313","MONDO_0002775","EFO_0001073","EFO_0000660","EFO_0003060","Orphanet_418","EFO_0009708","HP_0004322","EFO_0000304","EFO_0000553","EFO_0000731","MONDO_0011962","EFO_0000432","HP_0001510","EFO_0003833","MONDO_0024880","EFO_0003922","EFO_1000233"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 approved and 34 investigational indications."}
{"id":"CHEMBL1454","canonicalSmiles":"c1ccc([C@H]2CN3CCSC3=N2)cc1","inchiKey":"HLFSDGLLUJUHTE-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMISOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levamisole","TCMDC-125847"],"crossReferences":{"PubChem":["90341409"],"Wikipedia":["Levamisole"],"drugbank":["DB00848"],"chEBI":["6432"]},"childChemblIds":["CHEMBL1770"],"count":4,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for helminthiasis and has 3 investigational indications."}
{"id":"CHEMBL148756","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2Cc1ccccc1","inchiKey":"ZEKCBTQHDTUHRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148756","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1509531","canonicalSmiles":"CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1.Cl","inchiKey":"LYMNPRAIEYTRSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1509531","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1184360","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14740806"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1514931","canonicalSmiles":"[NH-]S(=O)(=O)Cc1noc2ccccc12.[Na+]","inchiKey":"ZVBIRPKGWOVBLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1514931","maximumClinicalTrialPhase":0,"parentId":"CHEMBL750","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153983","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCCOC(=O)c1cccnc1","inchiKey":"AYJVGKWCGIYEAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONIFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronifibrate"],"crossReferences":{"Wikipedia":["Ronifibrate"],"drugbank":["DB13460"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1558","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl","inchiKey":"WFXFYZULCQKPIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZOSIN HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphavase 0.5","Alphavase 1","Alphavase 2","Alphavase 5","Hypovase","Hypovase b.d.","Kentovace","Minipress","Minipress xl","Prazosin hydrochloride"],"synonyms":["CP-12,299-1","CP-12299-1","NSC-292810","Prazosin hydrochloride"],"crossReferences":{"DailyMed":["prazosin%20hydrochloride"],"PubChem":["26747647","26747648","50106894","50106895","50106896","56462999","572084","855727"],"chEBI":["8365"]},"count":1,"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","HP_0000726","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and has 1 investigational indication."}
{"id":"CHEMBL1568057","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"MKFFGUZYVNDHIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL SULFATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL776","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alupent","Alupent obstetric","Metaproterenol sulfate","Prometa"],"synonyms":["Metaproterenol sulfate","Orciprenaline sulfate","TH-152"],"crossReferences":{"DailyMed":["metaproterenol%20sulfate"],"PubChem":["170466142","50106554"]},"count":2,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","EFO_0000270"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for asthma and has 1 investigational indication."}
{"id":"CHEMBL1599","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1","inchiKey":"UQLLWWBDSUHNEB-CZUORRHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHAPIRIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefapirin","Cephapirin"],"crossReferences":{"Wikipedia":["Cefapirin"],"drugbank":["DB01139"],"chEBI":["554446"]},"childChemblIds":["CHEMBL1201043","CHEMBL3989837"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for bacterial disease."}
{"id":"CHEMBL1615777","canonicalSmiles":"N=C(N)NCc1cccc([123I])c1","inchiKey":"PDWUPXJEEYOOTR-IUAIQHPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE I 123","maximumClinicalTrialPhase":0,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iobenguane (123i)","Iobenguane i 123"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1615779","canonicalSmiles":"N=C(N)NCc1cccc([131I])c1","inchiKey":"PDWUPXJEEYOOTR-JRGAVVOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE I 131","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azedra"],"synonyms":["3-iodobenzylguanidine (131i)","Iobenguane (131 i)","Iobenguane (131i)","Iobenguane i 131","Iobenguane i-131","M131ibg"],"crossReferences":{"DailyMed":["iobenguane%20i-131"]},"count":3,"approvedIndications":["EFO_1000453","EFO_0000239"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0024503","EFO_1000453","EFO_0000239","EFO_0000621"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for paraganglioma and adrenal gland pheochromocytoma and has 1 investigational indication."}
{"id":"CHEMBL165024","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=N[C@@H](C)CO3)cc2)on1","inchiKey":"UXIYKMARWUSIKU-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL166","canonicalSmiles":"Nc1nc(N)nc(Nc2ccc([As]3SCC(CO)S3)cc2)n1","inchiKey":"JCYZMTMYPZHVBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELARSOPROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mel b","Melarsoprol","RP 3854","RP-3854"],"crossReferences":{"Wikipedia":["Melarsoprol"],"drugbank":["DB12864"],"chEBI":["6729"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1684984","canonicalSmiles":"CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21","inchiKey":"JEGHXKRHKHPBJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PA-799","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH-5132799","CH5132799","PA-799","PA799","Pa-799"],"crossReferences":{"drugbank":["DB13051"]},"count":1,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697733","canonicalSmiles":"CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C","inchiKey":"RDHQFKQIGNGIED-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCARNITINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nicetile"],"synonyms":["Acetyl-L-Carnitine","Acetyl-l-carnitine","Acetylcarnitine"],"crossReferences":{"Wikipedia":["Acetylcarnitine"],"drugbank":["DB08842"],"chEBI":["57589"]},"count":9,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 8 investigational indications."}
{"id":"CHEMBL1697844","canonicalSmiles":"O=C(OC[C@H]1O[C@](O)(COC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1","inchiKey":"FUWFSXZKBMCSKF-ZASNTINBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOFURANOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bradilan"],"synonyms":["ES 304","Nicofuranose"],"crossReferences":{"PubChem":["144205184"],"drugbank":["DB13422"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1726794","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.O=C(O)CCC(=O)O","inchiKey":"JMZPVBWHQMLKEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1726794","maximumClinicalTrialPhase":0,"parentId":"CHEMBL422","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["92764763","99516"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742991","drugType":"Antibody","blackBoxWarning":false,"name":"BENRALIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fasenra"],"synonyms":["BIW-8405","Benralizumab","MEDI-563"],"crossReferences":{"DailyMed":["benralizumab"]},"count":7,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000091181"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","HP_0006536","EFO_0005531","EFO_0007486","EFO_1000391","HP_0001871","EFO_0000270","EFO_0000341","EFO_0000274","EFO_1001467","EFO_0007187"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for asthma and airway obstruction and has 5 investigational indications."}
{"id":"CHEMBL1743008","drugType":"Antibody","blackBoxWarning":false,"name":"DROZITUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-DR5","ANTI-DR5 RHUMAB-DR5","Drozitumab","PRO-95780","RHUMAB DR5","RHUMAB-DR5"],"count":4,"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0005952","EFO_0003060","EFO_0000333","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743054","drugType":"Antibody","blackBoxWarning":false,"name":"OZORALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATN 103","ATN-103","Ozoralizumab"],"count":1,"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1743203","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4CC(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"SQGZFRITSMYKRH-QAGGRKNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"delta5-ADD","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["delta5-ADD"],"crossReferences":{"drugbank":["DB01456"],"chEBI":["83865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1744447","canonicalSmiles":"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]","inchiKey":"LALFOYNTGMUKGG-BGRFNVSISA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSUVASTATIN CALCIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1496","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crestor","Ezallor","Rosuvastatin calcium"],"synonyms":["Rosuvastatin calcium","Rosuvastatin calcium salt","S-4522","ZD-4522","ZD-4522 (CALCIUM SALT)","ZD4522 (CALCIUM SALT)"],"crossReferences":{"DailyMed":["rosuvastatin%20calcium"],"chEBI":["77249"]},"count":12,"approvedIndications":["EFO_0003774"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0002140","HP_0003124","EFO_0001645","EFO_0003774","EFO_1001461","EFO_0004911","Orphanet_309005","EFO_0000537","EFO_0004211","EFO_0003144","EFO_0001359","Orphanet_79211","EFO_0001360","EFO_0000400","EFO_0003918","EFO_0005672"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for hyperlipidemia and has 11 investigational indications."}
{"id":"CHEMBL1762","canonicalSmiles":"Cc1cccc(C)c1NC(=O)C(C)N","inchiKey":"BUJAGSGYPOAWEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOCAINIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tocainide","W-36095"],"crossReferences":{"PubChem":["90341559"],"Wikipedia":["Tocainide"],"drugbank":["DB01056"],"chEBI":["9611"]},"childChemblIds":["CHEMBL1200773"],"count":1,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1766","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"VWVSBHGCDBMOOT-IIEHVVJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOXIMETASONE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desoximetasone","Stiedex","Stiedex lp","Stiedex lpn","Topicort","Topicort lp"],"synonyms":["A-41-304","A-41304","Desoximetasone","HOE 304","HOE-304","J83.644C","R 2113","R-2113"],"crossReferences":{"DailyMed":["desoximetasone"],"PubChem":["144204440","170464795","29215017","56423147","855924"],"Wikipedia":["Desoximetasone"],"drugbank":["DB00547"],"chEBI":["691037"]},"count":1,"approvedIndications":["EFO_0000676"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for psoriasis."}
{"id":"CHEMBL17962","canonicalSmiles":"N[C@@H](Cc1c[nH]cn1)C(=O)O","inchiKey":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3694","Histidine","L-histidine","NSC-137773"],"crossReferences":{"PubChem":["11111281","90340851"],"Wikipedia":["Histidine"],"drugbank":["DB00117"],"chEBI":["15971"]},"childChemblIds":["CHEMBL1256578"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL180792","canonicalSmiles":"C[C@H](COc1ccc([C@@H]2Oc3ccc(O)cc3S[C@@H]2c2ccc(O)cc2)cc1)N1CCCC1","inchiKey":"UZOOIPXOYYJULJ-BLIZRMSTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180792","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02615"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184444","canonicalSmiles":"COC(=O)c1c(O)cccc1OC/C=C/c1cccc(-c2onc(C(=O)O)c2CO)c1","inchiKey":"DQSRCEFDWMQCCV-GQCTYLIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184444","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186113","canonicalSmiles":"CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(N[C@H](CO)Cc5ccccc5)nc43)[C@H](O)[C@@H]2O)n1","inchiKey":"FLBKPDIBGNWXMT-NIQZGXKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-328267","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW328267","GW328267X","Gw-328267","J2.047.755E"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL188225","canonicalSmiles":"O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@@H]12","inchiKey":"NAKUGCPAQTUSBE-IUCAKERBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL188225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855984"],"drugbank":["DB02414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1893913","canonicalSmiles":"CCCCNC(=O)OCC#CI","inchiKey":"WYVVKGNFXHOCQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOCARB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodocarb"],"crossReferences":{"PubChem":["144209062","144211434","26757795"],"drugbank":["DB15666"],"chEBI":["83279"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL189676","canonicalSmiles":"CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1","inchiKey":"HMXDWDSNPRNUKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURINABANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-147778","Sr147778","Surinabant"],"crossReferences":{"PubChem":["144210559"],"Wikipedia":["Surinabant"],"drugbank":["DB13070"]},"count":2,"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1909289","canonicalSmiles":"CCOC(Nc1ccc(C(=O)O)cc1)C(=O)c1ccc(-c2ccccc2)cc1","inchiKey":"BPOMPTVRBWXZBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENAZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Francia"],"classes":["Hepatotoxicity"],"year":1965},"tradeNames":[],"synonyms":["CV 58903","SKF-8318","Xenalamine","Xenazoic acid"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Francia  in 1965 due to Hepatotoxicity."}
{"id":"CHEMBL194805","canonicalSmiles":"CC(C)(c1ccccc1)c1ccc(O)cc1","inchiKey":"QBDSZLJBMIMQRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208495","144210376","17389498","26752848"],"drugbank":["DB06902"],"chEBI":["35092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O","inchiKey":"CIWBSHSKHKDKBQ-JLAZNSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASCORBIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascor","Ascorbicap","Ascur","Bassett's","Cebione","Cecon","Cenolate","Cetane","Cetane-caps tc","Cevalin","Cevex","Haliborange","Redoxon","Redoxon c","Redoxon chew-c","Redoxon slow release","Top c","Vital life","Vitamin C"],"synonyms":["Ascorbic Acid","Ascorbic acid","Ascorbic acid (vit c)","Cevitamic acid","E-300","E300","FEMA NO. 2109","INS NO.300","INS-300","NSC-218455","NSC-33832","Vitamin c"],"crossReferences":{"DailyMed":["ascorbic%20acid"],"PubChem":["144203866","144205657","144209325","144213275","170464728","17390038","26757776"],"Wikipedia":["Ascorbic_acid","Vitamin_C"],"drugbank":["DB00126"],"chEBI":["29073"]},"childChemblIds":["CHEMBL3350399"],"count":83,"approvedIndications":["EFO_0003106","EFO_0003966","EFO_0003884","EFO_0004272","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 78 investigational indications."}
{"id":"CHEMBL1972559","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.N","inchiKey":"NYUPFPFTYCWUEZ-YSMBQZINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1972559","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1206232","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["501403","502658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203836","canonicalSmiles":"NC(=O)c1cc(C(=O)O)cc(-c2ccc(-c3ccccc3)cc2)c1","inchiKey":"LAZPCGBRHLARSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203836","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04583"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2095209","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)OCC","inchiKey":"SSQPWTVBQMWLSZ-AAQCHOMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSAPENT ETHYL","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vascepa"],"synonyms":["AMR 101","AMR-101","AMR101","Eicosapentaenoic acid ethyl ester","Ethyl icosapentate","Icosapent ethyl"],"crossReferences":{"DailyMed":["icosapent%20ethyl"],"drugbank":["DB08887"],"chEBI":["80366"]},"count":6,"approvedIndications":["EFO_0004211"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for hypertriglyceridemia and has 5 investigational indications."}
{"id":"CHEMBL2096631","canonicalSmiles":"O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]","inchiKey":"QCHSEDTUUKDTIG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"CLORAZEPATE DIPOTASSIUM","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1213252","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clorazepate dipotassium","Gen-xene","Tranxene","Tranxene sd"],"synonyms":["4306 CB","ABBOTT-35616","Clorazepate dipotassium","Dipotassium clorazepate","Potassium Clorazepate"],"crossReferences":{"DailyMed":["clorazepate%20dipotassium"],"chEBI":["3762"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104940","canonicalSmiles":"CCC(C)N(CC(O)c1cccn1Cc1ccccc1Cl)C(C)CC","inchiKey":"ZILPIBYANAFGMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIMINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diviminol","Viminol","Z 424"],"crossReferences":{"drugbank":["DB13353"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105391","canonicalSmiles":"CCCOC(=O)c1sc(C(=O)OCCC)c(O)c1O","inchiKey":"GUFHWUFYAOUKTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTIOFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Protiofate"],"crossReferences":{"drugbank":["DB13632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106991","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](F)[C@@H](CO)O2)cc1Cl","inchiKey":"WKVDSZYIGHLONN-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALURIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["935-U-83","935U83","Raluridine"],"crossReferences":{"drugbank":["DB12894"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107906","drugType":"Unknown","blackBoxWarning":false,"name":"PLAGUE VACCINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plague vaccine"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108106","drugType":"Unknown","blackBoxWarning":false,"name":"TOCOPHERSOLAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eastman vitamin e tpgs","Vedrop"],"synonyms":["TPG-S","TPGS","Tocofersolan","Tocophersolan"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108299","drugType":"Unknown","blackBoxWarning":false,"name":"METFORMIN GLYCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMMET-01","Metformin glycinate"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108655","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLEVAMER POTASSIUM SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GT-267-004","GT-267004","GT267-004","Tolevamer potassium sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108671","drugType":"Antibody","blackBoxWarning":false,"name":"ACTOXUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mdx-066"],"synonyms":["Actoxumab","MDX-066"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108986","drugType":"Protein","blackBoxWarning":false,"name":"ARGIPRESSIN TANNATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pitressin tannate (synthetic)"],"synonyms":["Argipressin","Argipressin tannate","CI-107"],"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109101","drugType":"Antibody","blackBoxWarning":false,"name":"FELVIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Felvizumab","SB 209763","SB-209763"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109248","drugType":"Antibody","blackBoxWarning":false,"name":"APOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Apomab"],"synonyms":[],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109326","drugType":"Antibody","blackBoxWarning":false,"name":"MIK-BETA-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MIK-BETA-1","Mik-beta-1"],"count":1,"linkedTargets":{"rows":["ENSG00000100385"],"count":1},"linkedDiseases":{"rows":["EFO_0000565"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109434","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-GP100","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-GP100"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109475","drugType":"Antibody","blackBoxWarning":false,"name":"PG-102","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PG-102","Pg-102"],"count":1,"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109558","drugType":"Antibody","blackBoxWarning":false,"name":"MU-J591","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MU-J591","Mu-j591"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110809","canonicalSmiles":"CCCCSc1ccc(C(SCCN(C)C)c2ccccc2)cc1","inchiKey":"IZLPZXSZLLELBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPTODIAME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Captodiame"],"crossReferences":{"drugbank":["DB09014"]},"childChemblIds":["CHEMBL2106143"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111030","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2cccnc21","inchiKey":"JTTAUPUMOLRVRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTHIPENDYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Prothipendyl"],"crossReferences":{"drugbank":["DB12958"]},"childChemblIds":["CHEMBL2107124"],"count":5,"approvedIndications":["EFO_0005407"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL219445","canonicalSmiles":"COc1cc2ncnc(N3CC[C@@H](Oc4cnc5ccccc5n4)C3)c2cc1OC","inchiKey":"UBIIFKJMNRPNMT-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219445","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08391"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311115","canonicalSmiles":"O=C([O-])c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O.[Na+]","inchiKey":"RDHFCNKNCNJWHC-ANVLNOONSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYMER OF SULFASALAZINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL421","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Polymer of Sulfasalazine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2322189","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)([O-])O.[Na+]","inchiKey":"JHXHBFDOOUMZSP-LJUKVTEVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfomycin sodium","NSC-136017"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2355456","canonicalSmiles":"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"PCIOHQNIRPWFMV-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUTILIDE FUMARATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL533","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corvert","Ibutilide fumarate"],"synonyms":["Ibutilide fumarate","U-70226E"],"crossReferences":{"DailyMed":["ibutilide%20fumarate"],"PubChem":["144206557"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2364603","canonicalSmiles":"COc1c(N2CCC/C(=C(\\F)CN)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl","inchiKey":"RDXCNSOGHLLWDV-YFMOEUEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACORAFLOXACIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1257096","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acorafloxacin hydrochloride","Avarofloxacin hydrochloride","JNJ-32729463-AAC","JNJ-32729463AAC","Jnj-32729463"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364968","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"ZQLJWTRXKINMIN-BEJKIDSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOLOID","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["ergoloid%20mesylates"]},"childChemblIds":["CHEMBL2311030"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000135312","ENSG00000184160","ENSG00000274286","ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000151577","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000169676","ENSG00000150594"],"count":13},"linkedDiseases":{"rows":["EFO_0004718","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL252642","canonicalSmiles":"O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)ccc21","inchiKey":"FURUXTVZLHCCNA-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIQUIRTIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S)-Liquiritigenin","4',7-Dihydroxyflavanone","7,4'-Dihydroxyflavanone","Liquiritigenin","Liquirtigenin"],"crossReferences":{"drugbank":["DB03601"],"chEBI":["28777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257553","canonicalSmiles":"NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"TZHCXOMEOHEZDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257553","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25843","canonicalSmiles":"CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1","inchiKey":"YSGASDXSLKIKOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMACEMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Remacemide"],"crossReferences":{"drugbank":["DB06458"]},"childChemblIds":["CHEMBL1448437"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262747","canonicalSmiles":"CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(C)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1","inchiKey":"ZWNUQDJANZGVFO-YHSALVGYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ACYLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acyline","MER-104"],"crossReferences":{"drugbank":["DB11906"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL267227","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21","inchiKey":"HCAWPGARWVBULJ-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELTA 8-TETRAHYDROCANNOBINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delta 8-tetrahydrocannobinol"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL272706","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(O[14CH3])cccc2C4=O)C[C@H](N)[C@@H]1O","inchiKey":"AOJJSUZBOXZQNB-ZIKAUKRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272706","maximumClinicalTrialPhase":0,"parentId":"CHEMBL53463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL276520","canonicalSmiles":"c1ccc2c(CCC3CCNCC3)c[nH]c2c1","inchiKey":"SADQVAVFGNTEOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDALPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hematological toxicity"],"year":1985},"tradeNames":[],"synonyms":["Indalpine","LM-5008"],"crossReferences":{"Wikipedia":["Indalpine"],"drugbank":["DB08953"]},"childChemblIds":["CHEMBL2362557"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1985 due to Hematological toxicity."}
{"id":"CHEMBL280728","canonicalSmiles":"O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1","inchiKey":"GLLPUTYLZIKEGF-HAVVHWLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDOGREL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R 68070","R-68070","Ridogrel"],"crossReferences":{"drugbank":["DB01207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301523","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"COLNVLDHVKWLRT-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3585","L-phenylalanine","NSC-79477","Phenylalanine"],"crossReferences":{"PubChem":["124877007","124877010","26753740","4252550"],"Wikipedia":["Phenylalanine"],"drugbank":["DB00120"],"chEBI":["17295"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3039510","canonicalSmiles":"O=S(=O)(O)c1cccc2c(S(=O)(=O)O)cccc12.O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1.O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1","inchiKey":"YWFAHMIAJNFTHW-VRCDMBAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEDITEROL NAPADISYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3039530","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abediterol napadisylate","LAS100977 napadisylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039518","canonicalSmiles":"COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12","inchiKey":"URWYQGVSPQJGGB-DHUJRADRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATEFENTEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batefenterol","GSK-961081A","GSK961081","GSK961081A","TD-5959"],"crossReferences":{"drugbank":["DB12526"]},"childChemblIds":["CHEMBL3039512"],"count":1,"linkedTargets":{"rows":["ENSG00000169252","ENSG00000133019","ENSG00000181072"],"count":3},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL317052","canonicalSmiles":"CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1","inchiKey":"LZPZPHGJDAGEJZ-AKAIJSEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGADENOSON","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lexiscan"],"synonyms":["Regadenoson monohydrate"],"crossReferences":{"DailyMed":["regadenoson"],"PubChem":["170465244"],"drugbank":["DB06213"]},"childChemblIds":["CHEMBL3989695"],"count":2,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0001645","EFO_1001154","EFO_0000319"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 2 investigational indications."}
{"id":"CHEMBL3187096","canonicalSmiles":"CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)[C@@H](O)[C@H](O)C(=O)O","inchiKey":"GWHQHAUAXRMMOT-RWALOXMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187096","maximumClinicalTrialPhase":0,"parentId":"CHEMBL636","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206081","170464721"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL32190","canonicalSmiles":"COc1cc(CN(C)c2cnc3nc(N)nc(N)c3c2)cc(OC)c1OC","inchiKey":"PUOZHLHNKHRTOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL32190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02919"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3246831","canonicalSmiles":"Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccn1)=NC2","inchiKey":"BGRWSFIQQPVEML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3246831","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328250","canonicalSmiles":"CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2","inchiKey":"GJSLOMWRLALDCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADINAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adinazolam","U-41,123"],"crossReferences":{"Wikipedia":["Adinazolam"],"drugbank":["DB00546"],"chEBI":["251412"]},"childChemblIds":["CHEMBL2106672"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3360203","canonicalSmiles":"COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1","inchiKey":"QINPEPAQOBZPOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PILARALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pilaralisib","SAR-245408","SAR245408","Sar-245408","XL-147","XL147"],"crossReferences":{"drugbank":["DB11772"]},"count":8,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0011962","MONDO_0007254","EFO_0000574","EFO_0004230","EFO_0000519","EFO_0003060","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL340807","canonicalSmiles":"COc1ccc2c3c([nH]c2c1)C(C)=NCC3","inchiKey":"RERZNCLIYCABFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HARMALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Harmaline"],"crossReferences":{"PubChem":["11113138","11533026","124882832","124882834","124882835","26748426","26748427","26753726","26753727","50107396","50107397","56424137"],"Wikipedia":["Harmaline"],"drugbank":["DB13875"],"chEBI":["28172"]},"childChemblIds":["CHEMBL1494278","CHEMBL2089157","CHEMBL2165708","CHEMBL326436"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL346178","canonicalSmiles":"CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1","inchiKey":"DZOJBGLFWINFBF-UMSFTDKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSANETANT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Osanetant","SB-236984","SR-14280","SR-142801"],"crossReferences":{"Wikipedia":["Osanetant"],"drugbank":["DB04872"]},"childChemblIds":["CHEMBL2311148"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3526685","canonicalSmiles":"Cc1ccc(F)cc1[14C](=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1","inchiKey":"PPHTXRNHTVLQED-XTTHZMQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526685","maximumClinicalTrialPhase":0,"parentId":"CHEMBL49429","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL354201","canonicalSmiles":"CC1=C(C)C(=O)c2ccccc2C1=O","inchiKey":"LGFDNUSAWCHVJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Dimethyl-[1,4]Naphthoquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dimethyl-[1,4]Naphthoquinone"],"crossReferences":{"drugbank":["DB07669"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544959","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-382","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arry-382"],"count":1,"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544997","drugType":"Small molecule","blackBoxWarning":false,"name":"LS-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ls-104"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545083","canonicalSmiles":"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1","inchiKey":"XLSYZSRXVVCHLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RGB-286638","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RGB 286638","Rgb-286638"],"count":1,"linkedTargets":{"rows":["ENSG00000164885","ENSG00000134058","ENSG00000123374","ENSG00000135446","ENSG00000136807","ENSG00000170312"],"count":6},"linkedDiseases":{"rows":["EFO_0001642"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545137","canonicalSmiles":"Cn1cc(-c2nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3-c2c[nH][nH]c4=O)cn1","inchiKey":"YFNWWNRZJGMDBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00477736","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-00477736","PF-477736","Pf-00477736"],"count":1,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545191","drugType":"Antibody","blackBoxWarning":false,"name":"EVINACUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evinacumab","REGN-1500","REGN1500"],"count":4,"linkedTargets":{"rows":["ENSG00000132855"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","EFO_0000589","HP_0003124","Orphanet_391665"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545343","drugType":"Small molecule","blackBoxWarning":false,"name":"ADC3680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC3680B","Adc3680"],"count":1,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0010638"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545368","canonicalSmiles":"CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1","inchiKey":"XVDWNSFFSMWXJJ-ASTDGNLGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PANOBINOSTAT LACTATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL483254","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Farydak"],"synonyms":["Panobinostat lactate"],"crossReferences":{"DailyMed":["panobinostat%20lactate"],"chEBI":["85991"]},"count":1,"approvedIndications":["EFO_0001378"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000163517","ENSG00000147099","ENSG00000100429","ENSG00000116478","ENSG00000068024","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for multiple myeloma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545370","drugType":"Antibody","blackBoxWarning":false,"name":"EMACTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emactuzumab","RG-7155","RG7155","RO-5509554","RO5509554","RO5509554 (ANTI-CSF-R1)"],"count":3,"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005952","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545372","drugType":"Antibody","blackBoxWarning":false,"name":"SOFITUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-MUC16 ADC","DMUC-5754A","DMUC5754A","RG-7458","Sofituzumab vedotin"],"count":2,"linkedTargets":{"rows":["ENSG00000181143"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0008170"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3577957","canonicalSmiles":"Cl.O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1","inchiKey":"MRTJHEDYFUFHHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3577957","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103862","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL358064","canonicalSmiles":"CCCCOc1ccc(S(=O)(=O)N2C[C@@H](NS(C)(=O)=O)C[C@@H]2C(=O)NO)cc1","inchiKey":"ULDXUWXTVRRUND-SWLSCSKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL358064","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361348","canonicalSmiles":"CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(N[C@H]3CC[C@H](N)CC3)nc12","inchiKey":"MDIWBYRNTPTYQI-QAQDUYKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361348","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL369075","canonicalSmiles":"NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1","inchiKey":"VQWGYPVNVICKFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAPITADINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vapitadine"],"crossReferences":{"drugbank":["DB05738"]},"childChemblIds":["CHEMBL539843","CHEMBL1203919"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3707393","canonicalSmiles":"N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1.O=P(O)(O)O","inchiKey":"FMCPYRDGUZBOJZ-BTQNPOSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSILODROSTAT PHOSPHATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3099695","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isturisa"],"synonyms":["LCI699-AZA","Osilodrostat phosphate"],"crossReferences":{"DailyMed":["osilodrostat%20phosphate"]},"count":1,"approvedIndications":["EFO_1001110"],"linkedTargets":{"rows":["ENSG00000160882"],"count":1},"linkedDiseases":{"rows":["EFO_1001110"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for pituitary-dependent cushing's disease."}
{"id":"CHEMBL3707395","canonicalSmiles":"CSc1ccc(C(=O)/C=C/c2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1","inchiKey":"AFLFKFHDSCQHOL-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELAFIBRANOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elafibranor","GFT-505","GFT505","Gft505"],"crossReferences":{"drugbank":["DB05187"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3810125","canonicalSmiles":"O.O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1","inchiKey":"BNGZNZUNROGDHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3810125","maximumClinicalTrialPhase":0,"parentId":"CHEMBL21333","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL386051","canonicalSmiles":"CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1","inchiKey":"VAARYSWULJUGST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0173955","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-0173955","PD-17395"],"crossReferences":{"drugbank":["DB02567"],"chEBI":["49791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL388154","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"LFTYTUAZOPRMMI-CFRASDGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL388154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03397"],"chEBI":["16264"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3912251","canonicalSmiles":"Cc1cc(C(=O)O)ccc1COc1cc2c(cc1N(CC(C)C)S(=O)(=O)c1nccs1)CCC2","inchiKey":"ALLLQQUASFFEKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONO-8539","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONO-8539","Ono-8539"],"crossReferences":{"drugbank":["DB15325"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL39221","canonicalSmiles":"N[C@H](C(=O)O)c1cc(O)cc(O)c1","inchiKey":"HOOWCUZPEFNHDT-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-3,5-Dihydroxyphenylglycine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-3,5-Dihydroxyphenylglycine"],"crossReferences":{"PubChem":["11111063","11113456","11113714","26751901","50104578","50104579","90340619"],"drugbank":["DB04228"],"chEBI":["29474"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989936","canonicalSmiles":"C[C@]12C[C@H](c3ccc(S(C)(=O)=O)cc3)C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C(F)(F)C(F)(F)F","inchiKey":"JUFWQQVHQFDUOD-ANRPBIDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILAPRISAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1002670","BAY1002670","Vilaprisan"],"crossReferences":{"drugbank":["DB11971"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL400599","canonicalSmiles":"CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1","inchiKey":"CJAVTWRYCDNHSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENFLUOREX","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"," Respiratory toxicity"],"year":2009},"tradeNames":[],"synonyms":["Benfluorex"],"crossReferences":{"PubChem":["56320700"],"Wikipedia":["Benfluorex"],"drugbank":["DB09022"]},"childChemblIds":["CHEMBL1412305"],"count":2,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000057252"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in European Union  in 2009 due to Cardiotoxicity and  Respiratory toxicity."}
{"id":"CHEMBL404155","canonicalSmiles":"O=C(Cc1cccs1)N[C@H](B(O)O)c1ccccc1","inchiKey":"LGJCDEZMANATFA-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404155","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4161733","canonicalSmiles":"C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1","inchiKey":"KRTIYQIPSAGSBP-ZACQAIPSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4161733","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417844","canonicalSmiles":"C=C=CCNCCCCNCC=C=C","inchiKey":"IKSQCMLJDHRWOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL417844","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04188"]},"childChemblIds":["CHEMBL4439012"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4282338","canonicalSmiles":"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc([S@](=N)(=O)C3CC3)cc2)ncc1C(F)(F)F","inchiKey":"UELYDGOOJPRWGF-SRQXXRKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4282338","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297213","canonicalSmiles":"CC(=O)O.CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"LBIUKNXYUXOWFF-CRYSLBJVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AFAMELANOTIDE ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL441738","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Scenesse"],"synonyms":["Afamelanotide acetate","CUV1647 ACETATE"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297422","canonicalSmiles":"CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21","inchiKey":"OJPLJFIFUQPSJR-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-4733","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO 4929097","RO-4929097","Rg 4733","Rg-4733","Ro4929097"],"crossReferences":{"drugbank":["DB11870"]},"count":19,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL4297508","canonicalSmiles":"CC(C)C[C@@H](C(=O)Nc1ccn(C[C@@H](O)CO)n1)N1CC(Oc2ccccc2Cl)=CC1=O","inchiKey":"HMUMWSORCUWQJO-QAPCUYQASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORZAGLIATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorzagliatin","HMS-5552","HMS5552","Hms5552","RO-5305552","RO5305552"],"crossReferences":{"drugbank":["DB15123"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297562","drugType":"Unknown","blackBoxWarning":false,"name":"DKN-01","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DKN-01","Dkn-01","LY-2812176","LY2812176"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297565","drugType":"Antibody","blackBoxWarning":false,"name":"CERTOLIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Certolizumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297631","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21","inchiKey":"RRTPWQXEERTRRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELRATOLIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3M-052","MEDI9197","Medi 9197","Medi9197","Telratolimod"],"count":2,"linkedTargets":{"rows":["ENSG00000101916","ENSG00000196664"],"count":2},"linkedDiseases":{"rows":["EFO_0000764","EFO_0002913"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297676","canonicalSmiles":"Cl.O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F","inchiKey":"HIEXZUXKTABHCP-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMASERTIB HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2107832","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 1036950","EMD-1036950","MSC-1936369B","MSC1936369B","Msc1936369b","Pimasertib hydrochloride"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297684","drugType":"Protein","blackBoxWarning":false,"name":"ABICIPAR PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-150998","Abicipar pegol","Agn-150998","MP-0112","MP-0260","MP0112","Mp0112","P7FHD7AG35"],"count":3,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297697","drugType":"Unknown","blackBoxWarning":false,"name":"AVI-7288","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avi-7288"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297717","drugType":"Unknown","blackBoxWarning":false,"name":"CD24FC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd24fc"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000204388","ENSG00000204389","ENSG00000189403","ENSG00000142512","ENSG00000096384"],"count":6},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100096","EFO_0002617"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297805","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06671008","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06671008","Pf-06671008"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297821","drugType":"Unknown","blackBoxWarning":false,"name":"RSLV-132","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rslv-132"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297848","drugType":"Antibody","blackBoxWarning":false,"name":"VOFATAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-FGR3","B-701","MFGR-1877A","MFGR-1877S","MFGR1877A","MFGR1877S","Mfgr1877s","Vofatamab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297991","drugType":"Unknown","blackBoxWarning":false,"name":"IMGN-632","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-632","IMGN632","Imgn-632","Imgn632"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298000","drugType":"Antibody","blackBoxWarning":false,"name":"ONVATILIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-61610588","JNJ61610588","Jnj-61610588","Onvatilimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298081","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATOPOIETIN-A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hepatocyte growth factor","Hepatopoietin-a","Recombinant human hepatocyte growth factor"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303472","canonicalSmiles":"CNCCc1ccccn1.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"ZBJJDYGJCNTNTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303472","maximumClinicalTrialPhase":0,"parentId":"CHEMBL24441","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442951","canonicalSmiles":"CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HOVAGTYPODGVJG-VOQCIKJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Methyl Beta-D-Galactopyranoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Beta-D-Galactopyranoside","Methyl Beta-D-Galactoside"],"crossReferences":{"PubChem":["24823989"],"drugbank":["DB04046"],"chEBI":["17540"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443030","canonicalSmiles":"COc1cc(CN2C(=O)N(Cc3ccc(O)c(OC)c3)N(Cc3ccccc3)C[C@@H](O)[C@H]2Cc2ccccc2)ccc1O","inchiKey":"PMBZSBGCSQGJAQ-GRKNLSHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL443030","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4440620","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"DQHNAVOVODVIMG-FOGIBKMMSA-M","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4440620","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1900528","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4524472","canonicalSmiles":"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O","inchiKey":"RXDWJNODTRVCER-WLHGVMLRSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4524472","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301622","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594244","drugType":"Small molecule","blackBoxWarning":false,"name":"HYALURONATE SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Legend"],"synonyms":["Hyaluronate sodium","Hyaluronic acid sodium salt","Sodium hyaluronate","Sodium hyaluronate for ir identification"],"count":10,"approvedIndications":["HP_0200042","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for skin ulcer and nasal obstruction and has 8 investigational indications."}
{"id":"CHEMBL4594246","canonicalSmiles":"CCC(CC)C(=O)OCOC(=O)C1=C(S[C@H]2CC[S+]([O-])C2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12","inchiKey":"NBPVNGWRLGHULH-JKOUTOBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULOPENEM ETZADROXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03709270","PF03709270","Sulopenem etzadroxil"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594434","canonicalSmiles":"C[C@H](NC(=O)/C(C#N)=C/C=C/c1cccc(Br)n1)c1ccccc1","inchiKey":"IVAUEQVCSQZMGV-QIUCFAMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOL-4239","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MOL-4239","MOL4239","Mol-4239","Mol4239","WP-1220","WP1220"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594462","drugType":"Unknown","blackBoxWarning":false,"name":"AVB-S6-500","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVB S6 500","AVB-S6-500","AVBS6500","Avb-s6-500","RUGA-S6"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594483","drugType":"Unknown","blackBoxWarning":false,"name":"NY-ESO-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NY-ESO-1","Ny-eso-1"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46102","canonicalSmiles":"CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1","inchiKey":"SMTZFNFIKUPEJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXATIDINE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Roxatidine","Roxatidine acetate"],"crossReferences":{"Wikipedia":["Roxatidine"],"drugbank":["DB08806"]},"childChemblIds":["CHEMBL2104871"],"count":2,"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["HP_0004398","EFO_0003948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL464792","canonicalSmiles":"CC(/C=C/C=C(\\C)C(=O)O)=C\\C=C\\C=C(C)\\C=C\\C=C(/C)C(=O)O","inchiKey":"PANKHBYNKQNAHN-MQQNZMFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROCETIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-75100","Crocetin","NSC-407300","Transcrocetin"],"crossReferences":{"Wikipedia":["Crocetin"],"drugbank":["DB05974"],"chEBI":["3918"]},"childChemblIds":["CHEMBL3137335"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL491571","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12","inchiKey":"AVAACINZEOAHHE-VFZPANTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORIPENEM","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doribax","Finibax"],"synonyms":["Doripenem","S-4661"],"crossReferences":{"PubChem":["144206061","170465085"],"Wikipedia":["Doripenem"],"drugbank":["DB06211"]},"childChemblIds":["CHEMBL4303454","CHEMBL1276416"],"count":7,"approvedIndications":["EFO_0003103","EFO_0000771","EFO_0000544","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL49642","canonicalSmiles":"O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12","inchiKey":"SOLIIYNRSAWTSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-24851","Indibulin","ZIO-301"],"crossReferences":{"PubChem":["174007308"],"drugbank":["DB06169"]},"count":3,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL501680","canonicalSmiles":"C=CC1=C(C)/C(=C/c2[nH]c(Cc3[nH]c(/C=C4\\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)NC1=O","inchiKey":"BPYKTIZUTYGOLE-IFADSCNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILIRUBIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bilirubin","NSC-26685"],"crossReferences":{"PubChem":["26749657"],"Wikipedia":["Bilirubin"],"chEBI":["16990"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL508338","drugType":"Small molecule","blackBoxWarning":false,"name":"THIMEROSAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Merthiolate"],"synonyms":["Ethylmercury sodium salt","Mercurothiolate","Merfamin","Mertorgan","Merzonin","NSC-4794","Sodium ethylmercurithiosalicylate","Thimerosal","Thiomersal","Thiomersalate"],"crossReferences":{"DrugCentral":["4733"],"PubChem":["144204884","144212493","170465469","26748268","26757844","57260470","57264345"],"Wikipedia":["Thiomersal"],"chEBI":["9546"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL514","canonicalSmiles":"O=NN(CCCl)C(=O)NC1CCCCC1","inchiKey":"GQYIWUVLTXOXAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOMUSTINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ccnu","Ceenu","Gleostine"],"synonyms":["CCN-U","CCNU","Lomustine","NSC-79037"],"crossReferences":{"DailyMed":["lomustine"],"PubChem":["119147","144206023","170464967","174007397","50112720"],"TG-GATEs":["49"],"Wikipedia":["Lomustine"],"drugbank":["DB01206"],"chEBI":["6520"]},"childChemblIds":["CHEMBL3250425","CHEMBL3250423","CHEMBL3250424"],"count":25,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for neoplasm and has 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL514446","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@@]21C","inchiKey":"OHXPGWPVLFPUSM-KLRNGDHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEHYDROCHOLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decholin","Dilabil","Procholon"],"synonyms":["Dehydrocholic acid"],"crossReferences":{"PubChem":["144205072","170465502","56422207","855992"],"Wikipedia":["Dehydrocholic_acid"],"drugbank":["DB11622"],"chEBI":["31459"]},"childChemblIds":["CHEMBL2106184"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL54","canonicalSmiles":"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"LNEPOXFFQSENCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HALOPERIDOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolpin","Dozic","Fortunan","Haldol","Haldol solutab","Haloperidol","Kentace","Keselen","Serenace"],"synonyms":["Haloperidol","Haloperidol decanoate impurity, haloperidol-","MCN-JR-1625","NSC-170973","NSC-615296","R-1625"],"crossReferences":{"DailyMed":["haloperidol","haloperidol%20lactate"],"PubChem":["104171168","11111260","11112116","11113356","124880286","124880288","124880291","124880292","144203713","144210793","170464841","26747061","26747062","26751574","26751575","487337","50100251","50104201","50104202","56422397","85231072","855969","90341418"],"TG-GATEs":["36"],"Wikipedia":["Haloperidol"],"drugbank":["DB00502"],"chEBI":["5613"]},"childChemblIds":["CHEMBL2096643","CHEMBL4297147","CHEMBL1160253","CHEMBL545608","CHEMBL2234294"],"count":18,"approvedIndications":["EFO_0004216","EFO_0004895","EFO_0005407","EFO_0000692","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0004216","EFO_0005323","HP_0000726","EFO_0000249","EFO_0003821","EFO_0003015","EFO_0003768","EFO_0005407","EFO_0009267","EFO_1000948","EFO_0003843","HP_0002018","HP_0000713","EFO_0007191","Orphanet_399","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0004895","EFO_0004888","EFO_0005230","EFO_0000692","EFO_0005411","EFO_0009954"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 5 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL545787","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.Cl","inchiKey":"UKBBZNRSHOCRNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL545787","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590","canonicalSmiles":"CC1=CC(=O)c2ccccc2C1=O","inchiKey":"MJVAVZPDRWSRRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENADIONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kappaxin","Kayquinone","Menadione","Vitamin K 3"],"synonyms":["Menadione","Menaphthene","Menaphthone","NSC-4170"],"crossReferences":{"PubChem":["104171275","11112142","11532917","144203885","144211684","170464997","174006181","174316135","26748651","56422378","70547"],"Wikipedia":["Menadione"],"drugbank":["DB00170"],"chEBI":["28869"]},"count":1,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hemorrhage."}
{"id":"CHEMBL606260","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]","inchiKey":"RTYJTGSCYUUYAL-YCAHSCEMSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1214","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geopen","Pyopen"],"synonyms":["BRL-2064","CP-15-639-2","Carbenicillin disodium","Carbenicillin disodium salt","Carbenicillin sodium","NSC-111071"],"crossReferences":{"PubChem":["144204857","170465106","855754"],"chEBI":["34609"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL609147","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2ccccc2)CC1","inchiKey":"GARXJOUQUSNOGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-30490","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-30490"],"crossReferences":{"Wikipedia":["R-30490"],"drugbank":["DB09179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL718","canonicalSmiles":"CC(N)(Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"CJCSPKMFHVPWAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPA (RACEMIC)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-3-(3,4-Dihydroxy-Phenyl)-2- Methyl-Propionic Acid(Catechol Metabolite)","Methyldopa","Methyldopa (racemic)","Methyldopa dl-form"],"crossReferences":{"PubChem":["174006847","50106598","50106599","85231121","90340754"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL727","canonicalSmiles":"Nc1nc2[nH]cnc2c(=S)[nH]1","inchiKey":"WYWHKKSPHMUBEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOGUANINE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lanvis","Tabloid","Thioguanine"],"synonyms":["NSC-752","NSC-76504","Thioguanine","Tioguanine","Tioguanine hemihydrate"],"crossReferences":{"PubChem":["144204586","144206735","144209599","144210595","170464908","174007001","26748270","538243","57260104","57264437"],"Wikipedia":["Tioguanine"],"drugbank":["DB00352"],"chEBI":["9555"]},"count":25,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000106348","ENSG00000178035"],"count":2},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0003812","EFO_1001945","EFO_0000209","EFO_0005952","MONDO_0003541","EFO_0000565","EFO_0004251","EFO_1000318","EFO_0004289","EFO_0000330","MONDO_0001657","EFO_0000183","MONDO_0020743","EFO_0000198","EFO_0000616","EFO_0003802","EFO_0000221","EFO_1001779","EFO_0000220","MONDO_0019457","EFO_0000223","EFO_0000222","EFO_1001946","MONDO_0000870","EFO_0003029","EFO_0003025","MONDO_0044917","EFO_1001936","EFO_0000574","EFO_1001947","EFO_0000218","EFO_0003833","EFO_0000519","MONDO_0021640","EFO_0003027","EFO_0003811"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for neoplasm and has 24 investigational indications."}
{"id":"CHEMBL7983","canonicalSmiles":"CCCOC(=O)c1cc(O)c(O)c(O)c1","inchiKey":"ZTHYODDOHIVTJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYL GALLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-310","E310","FEMA NO. 2947","INS NO.310","INS-310","NSC-2626","Propyl gallate"],"crossReferences":{"PubChem":["144207080","144209484","144210380","225144253","26757651","69249"],"Wikipedia":["Propyl_gallate"],"drugbank":["DB12450"],"chEBI":["10607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL838","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O","inchiKey":"XPCFTKFZXHTYIP-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENAZEPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benazepril","C09AA07","CGS-14824A","Lotensin","Lotrel"],"crossReferences":{"DailyMed":["benazepril%20hydrochloride"],"Wikipedia":["Benazepril"],"drugbank":["DB00542"],"chEBI":["3011"]},"childChemblIds":["CHEMBL1694"],"count":7,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["Orphanet_63","EFO_0003914","EFO_0003086","HP_0003124","Orphanet_79292","EFO_0002690","EFO_0001645","EFO_0000319","EFO_0004285","EFO_0000400","EFO_0001360","EFO_0000407","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for cardiovascular disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
